Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- Check3 days agoChange DetectedNapoli, Italy 80131 was replaced with Naples, Italy 80131 in the location list, and the revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check11 days agoChange DetectedThe study status was updated to Completed with a completion date of 2026-01-20; the previous Active, not recruiting status was removed.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated to v3.4.2. Previous revision v3.4.1 has been removed.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed, a minor internal update with no user-visible impact; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedGlossary display has been added, and the QC status label now reads 'Last Update Submitted that Met QC Criteria' with a corresponding 'No FEAR Act Data' notice; the page footer now shows 'Revision: v3.4.0'. The older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.